BMO Capital Downgrades Verve Therapeutics (VERV) to Market Perform
Go back to BMO Capital Downgrades Verve Therapeutics (VERV) to Market Perform| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1180.16 -27.11 (2.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1207.27 | 52 Week High | $88.16 | |||
| Open | $1194.01 | 52 Week Low | $67.88 | |||
| Day High | $1199.00 | P/E | 273.19 | |||
| Day Low | $1171.20 | EPS | $4.32 | |||
| Volume | 2,273,559 | |||||
| (NASDAQ: VERV) | Delayed: 11.13 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.13 | 52 Week High | $ | |||
| Open | $11.13 | 52 Week Low | $ | |||
| Day High | $11.13 | P/E | N/A | |||
| Day Low | $11.13 | EPS | $ | |||
| Volume | 117,252 | |||||
